The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant FOLFOX IV.
Anna Maria Frezza
No relevant relationships to disclose
Gaia Schiavon
No relevant relationships to disclose
Bruno Vincenzi
No relevant relationships to disclose
Raffaele Addeo
No relevant relationships to disclose
Vincenzo Catalano
No relevant relationships to disclose
Francesco Graziano
No relevant relationships to disclose
Daniele Santini
No relevant relationships to disclose
Giuseppe Tonini
No relevant relationships to disclose